Cargando…
Breast cancer cell-derived extracellular vesicles promote CD8(+) T cell exhaustion via TGF-β type II receptor signaling
Cancer immunotherapies have shown clinical success in various types of tumors but the patient response rate is low, particularly in breast cancer. Here we report that malignant breast cancer cells can transfer active TGF-β type II receptor (TβRII) via tumor-derived extracellular vesicles (TEV) and t...
Autores principales: | Xie, Feng, Zhou, Xiaoxue, Su, Peng, Li, Heyu, Tu, Yifei, Du, Jinjin, Pan, Chen, Wei, Xiang, Zheng, Min, Jin, Ke, Miao, Liyan, Wang, Chao, Meng, Xuli, van Dam, Hans, ten Dijke, Peter, Zhang, Long, Zhou, Fangfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343611/ https://www.ncbi.nlm.nih.gov/pubmed/35915084 http://dx.doi.org/10.1038/s41467-022-31250-2 |
Ejemplares similares
-
Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
por: Xie, Feng, et al.
Publicado: (2019) -
Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID‐19 Therapy
por: Xie, Feng, et al.
Publicado: (2021) -
FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis
por: Xie, Feng, et al.
Publicado: (2017) -
Regulation of endothelial cell plasticity by TGF-β
por: van Meeteren, Laurens A., et al.
Publicado: (2011) -
TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
por: Drabsch, Yvette, et al.
Publicado: (2011)